VIVUS, Inc.
1172 Castro Street
Mountain View
California
94040
United States
Tel: 650-934-5200
Fax: 650-934-5389
Website: http://www.vivus.com/
Email: ir@vivus.com
429 articles about VIVUS, Inc.
-
VIVUS, Inc. To Present At Upcoming Investor Conference
12/2/2013
-
VIVUS, Inc. Announces Support For New Obesity Treatment Guidance Urging Active Involvement From Healthcare Providers
11/21/2013
-
VIVUS, Inc. Announces Issuance Of Two Key U.S. Patents For Qsymia; Patent Coverage For Qsymia Extended To 2029
11/13/2013
-
VIVUS, Inc. to Present at Upcoming Investor Conference
11/12/2013
-
VIVUS, Inc. Announces Scientific Presentations
11/12/2013
-
Struggling VIVUS, Inc. Cuts 20 Jobs to Conserve Cash, Change CFOs
11/7/2013
-
Newly Published Study Finds VIVUS, Inc.'s Qsymia Achieves Greater Weight Loss at Lower Doses Than Either of Its Components as Monotherapy
10/31/2013
-
VIVUS, Inc., Auxilium Pharmaceuticals Ink $300 Million Pact for Erectile Dysfunction Drug Stendra
10/11/2013
-
VIVUS, Inc. Says Drug Delayed Progression to Diabetes
10/10/2013
-
VIVUS, Inc. President to Quit Oct. 12
9/30/2013
-
VIVUS, Inc. Updates European Filing Strategy for Qsiva
9/20/2013
-
Newly Named VIVUS, Inc. CEO Resigns Due to Health Concerns, Ex-Johnson & Johnson Exec to Take Over
9/4/2013
-
VIVUS, Inc. Reports Second Quarter and First Six Months 2013 Financial Results
8/7/2013
-
New VIVUS, Inc. CEO to Focus on Retail Push for Diet Pill
8/7/2013
-
VIVUS, Inc. Announces Date of Second Quarter 2013 Financial Results and Conference Call
8/5/2013
-
VIVUS, Inc. Announces Commercial Supply Agreement With Sanofi (France) to Produce Avanafil
8/1/2013
-
Smackdown: Another VIVUS, Inc. Offer is Rejected by First Manhattan
7/17/2013
-
VIVUS, Inc. Says It's Victim of False Statements, Delays Shareholder Meet
7/15/2013
-
VIVUS, Inc. Extends Invitation to First Manhattan for Three of Their Nominees to Join the Board of Directors
7/15/2013
-
VIVUS, Inc. Reminds Stockholders to Vote the GOLD Proxy Card by Telephone or Internet Today
7/11/2013